Dao Chao Huang

Dao Chao Huang is a prominent inventor based in Montreal, Canada. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. With a total of 3 patents, Huang's work focuses on the inhibition of cancer through the use of specific antibodies.

Latest Patents

Huang's latest patents include a method for inhibiting cancer in mammals by administering an antibody to PTHrP. This method aims to treat various types of cancer, including breast, lung, prostate, melanoma, and squamous cancer. The patent details the use of a PTHrP inhibitor that specifically binds to an epitope of the C-terminal portion of the human PTHrP1-173 isoform. Another significant patent addresses the diagnosis and treatment of diseases through the inhibition of PTHrP and its isoforms. This invention is particularly relevant for inhibiting tumor growth and its progression to metastatic sites.

Career Highlights

Throughout his career, Dao Chao Huang has worked with notable companies such as Biochrom Pharma Inc. and Softscan Healthcare Group Ltd. His expertise in the field has led to advancements in cancer treatment methodologies.

Collaborations

Huang has collaborated with esteemed colleagues, including Richard Kremer and Guobin Ma. These partnerships have further enhanced his research and contributions to the medical field.

Conclusion

Dao Chao Huang's innovative work in cancer treatment exemplifies the impact of dedicated research and invention. His patents reflect a commitment to improving therapeutic options for patients facing various types of cancer.

Profile summary based on public USPTO records.